The Medical Collagen Market Size was valued at USD 6.71 billion in 2022, and is expected to reach USD 11.02 billion by 2030, and grow at a CAGR of 6.4% over the forecast period 2023-2030.
Medical Collagen is an important protein in the human body's connective tissues. Medical collagen offers a wide range of applications in surgery and illness therapy. It's utilised for bone restoration, dental surgery, and bovine treatment in aesthetic surgery. Medical collagen is widely used in the orthopedic business because it strengthens bones and prevents them from breaking down. Medical Collagen is employed for tissue regeneration since it contains cell deposition and hydrophilicity qualities.
Get more information on Medical Collagen Market - Request Sample Report
Collagen is essential for healthy joints because it gives structure to the skin, joints, and bones, as well as aiding in blood clotting. It is one of the most important components of human skin, accounting for over 75percent of the skin's support structure. Collagen is commonly utilised in cosmetic surgery and as a burn victim's wound healing treatment. They're also commonly employed for bone rebuilding and a number of dental, orthopedic, and surgical procedures. In the approaching years, the pharmaceutical and health-care industries are projected to provide attractive prospects for collagen manufacturers.
It is used to treat wounds because of its great antibacterial qualities and sterility. Collagen is used by medical research organisations to examine the behavior of cells and their interactions with the other cells in the human body. Collagen is utilized to support cell proliferation in lattice structures and cell-binding regions in cell cultures. The use of regenerative operations to treat skin malignancies, burn injuries, and birth deformities is projected to propel the industry forward. Medical collagen is also commonly utilised in the treatment of cardiovascular problems.
DRIVERS
Collagen's Use in the Medical Industry is Increasing
Approvals from the FDA are increasing, and new products are being introduced.
RESTRAINTS
Treatment's exorbitant expenses
Low reimbursements stifle expansion.
OPPORTUNITIES
Emerging economies provide enormous prospects.
CHALLENGES
Processing technology that is insufficient
By Product:
Gelatin, hydrolyzed collagen, native collagen, and others make up the medical collagen market. In 2021, the gelatin segment had the biggest market share, and it is expected to grow at the fastest rate over the forecast period.
By Application:
Hemostats, vascular grafts, tissue scaffolds, cartilage repair, wound care, bone grafts, diagnostics, and other are the different segments of the medical collagen market. In 2021, the wound care sector had the biggest share, and the market for bone grafts is expected to grow at the fastest rate over the forecast period.
By Source:
Divided into bovine, porcine, and other categories. In 2021, the bovine segment accounted for the greatest proportion of the market, and it is expected to grow at the fastest rate over the forecast period.
By Source
Porcine
Bovine
Others
By Product
Hydrolysed Collagen
Gelatine
Native Collagen
Others
By Application
Cartilage Repair
Bone Grafts
Tissue Scaffolds
Diagnostics
Vascular Grafts
Hemostats
Other
.png)
Need any customization research on Medical Collagen Market - Enquiry Now
The world market for medical collagen was controlled by North America. Medical collagen is used in reconstructive surgeries, tissue engineering, bone grafts, wound and burn damage treatments, and other applications, which is driving the market expansion in the region. In addition, the market's expansion is aided by frequent product introductions. Collagen Matrix, Inc.'s revolutionary brand of Mineral Collagen Composite Bioactive Moldable Bone Graft Matrix got FDA approval in April 2019. The OssiMend Bioactive Moldable Bone Graft Matrix is a unique blend of organic carbonate apatite bone mineral, 45S5 bioactive glass, and highly purified Type I collagen that can be moulded into putty to fill uneven defect locations. The new matrix is part of the company's extensive line of collagen and mineral-based medical devices that can be implanted.
REGIONAL COVERAGE:
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
south Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Some of the major key players are as follows: Collplant Biotechnologies Ltd, Collagen Solutions Plc, Croda Interntional PLC., Collagen Matrix Inc., DSM, Encoll, Gelita AG, Integra Lifesciences Corporation, Innocoll, Symatese, and Other players.
| Report Attributes | Details |
|---|---|
| Market Size in 2022 | US$ 6.71 Billion |
| Market Size by 2030 | US$ 11.02 Billion |
| CAGR | CAGR of 6.4% From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2020-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Source (Porcine, Bovine, Others) • By Product (Hydrolysed Collagen, Gelatine, Native Collagen, Others) • By Application (Wound Care, Cartilage Repair, Bone Grafts, Tissue Scaffolds, Diagnostics, Vascular Grafts, Hemostats, Other) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Collplant Biotechnologies Ltd, Collagen Solutions Plc, Croda Interntional PLC., Collagen Matrix Inc., DSM, Encoll, Gelita AG, Integra Lifesciences Corporation, Innocoll, Symatese, and other players. |
| DRIVERS | • Collagen's Use in the Medical Industry is Increasing • Approvals from the FDA are increasing, and new products are being introduced. |
| RESTRAINTS | • Treatment's exorbitant expenses • Low reimbursements stifle expansion. |
Ans: The Medical Collagen Market size was valued at US$ 6.71 billion in 2022.
Collagen's Use in the Medical Industry is Increasing, Approvals from the FDA are increasing, and new products are the drivers of medical collagen market.
Market for medical collagen was controlled by North America.
The gelatin segment had the biggest market share, and it is expected to grow at the fastest rate over the forecast period.
Ans: The Medical Collagen Market is to growth 6.4% over the forecast period 2023-2030.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia War
4.3 Impact of Ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Medical Collagen Market Segmentation, By Source
8.1 Porcine
8.2 Bovine
8.3 Others
9. Medical Collagen Market Segmentation, By Product
9.1 Hydrolysed Collagen
9.2 Gelatine
9.3 Native Collagen
9.4 Others
10. Medical Collagen Market Segmentation, By Application
10.1 Wound Care
10.2 Cartilage Repair
10.3 Bone Grafts
10.4 Tissue Scaffolds
10.5 Diagnostics
10.6 Vascular Grafts
10.7Haemostats
10.8 Other
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 USA
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 The Netherlands
11.3.7 Rest of Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 South Korea
11.4.3 China
11.4.4 India
11.4.5 Australia
11.4.6 Rest of Asia-Pacific
11.5 The Middle East & Africa
11.5.1 Israel
11.5.2 UAE
11.5.3 South Africa
11.5.4 Rest
11.6 Latin America
11.6.1 Brazil
11.6.2 Argentina
11.6.3 Rest of Latin America
12. Company Profiles
12.1 Collplant Biotechnologies Ltd
12.1.1 Financial
12.1.2 Products/ Services Offered
12.1.3 SWOT Analysis
12.1.4 The SNS view
12.2 Collagen Solutions Plc
12.3 Croda Interntional PLC.
12.4 Collagen Matrix Inc.
12.5 DSM
12.6 Encoll
12.7 Gelita AG
12.8 Integra Lifesciences Corporation
12.9 Innocoll
12.10 Symatese
13. Competitive Landscape
13.1 Competitive Benchmark
13.2 Market Share Analysis
13.3 Recent Developments
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Behavioral Health Software Market Size was valued at USD 2.9 billion in 2023 and is expected to reach USD 11.6 billion by 2031 and grow at a CAGR of 19.0% over the forecast period 2024-2031.
The Ultrasound gels market size is projected to grow from $95.85 million in 2022 to $124.2 million by 2030, at a CAGR of 3.3% during the forecast period.
The Bio Decontamination Market size was estimated USD 225 million in 2022 and is expected to reach USD 410.3 million by 2030 at a CAGR of 7.8% during the forecast period of 2023-2030.
The Medical Device Reprocessing Market size was estimated at USD 2.2 billion in 2022 and is expected to reach USD 6.10 billion by 2030 at a CAGR of 13.6% during the forecast period of 2023-2030.
The Clinical Decision Support Systems Market Size was valued at USD 5.08 billion in 2022 and is expected to reach USD 11.04 billion by 2030, and grow at a CAGR of 10.2% over the forecast period 2023-2030.
The Patient Engagement Solutions Market Size was valued at USD 19.45 billion in 2022, and is expected to reach USD 69.25 billion by 2030 and grow at a CAGR of 17.2% over the forecast period 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
